Modiblast Pharma
Modiblast pursues a novel in vivo cell reprogramming approach to treat hematological malignancies and other cancers. Our proprietary strategy aims to drive innate & adaptive immune responses and establish memory cells. With our lead pipeline program progressing towards a first clinical trial in acute myeloid leukemia (AML), we are in the process of raising our seed round. Our long-term vision is to establish a cancer backbone therapy capable of prolonging phases in remission. We aim to enable...
Private Company
Funding information not available
About
Modiblast pursues a novel in vivo cell reprogramming approach to treat hematological malignancies and other cancers. Our proprietary strategy aims to drive innate & adaptive immune responses and establish memory cells. With our lead pipeline program progressing towards a first clinical trial in acute myeloid leukemia (AML), we are in the process of raising our seed round. Our long-term vision is to establish a cancer backbone therapy capable of prolonging phases in remission. We aim to enable...